Yvonne W. Chan

Ms. Chan represents clients in a range of highly-regulated industries. Ms. Chan’s work for clients has included the following:

• A month-long jury trial resulting in an acquittal for the former president of a pharmaceutical company in a federal criminal anti-kickback case involving allegations that the defendant had directed kickbacks to prescribers in the form of free meals and fees for speaking engagements.
• A verdict in favor of a financial institution after a bench trial in a bankruptcy adversary proceeding.
• A three-week arbitration on behalf of a global private equity firm which resulted in a $170 million award in favor of the firm. The arbitrator found that the respondents had committed fraud and breached their fiduciary duties, and awarded damages in the amount of the private equity firm’s entire investment, as well as additional damages for breach of fiduciary duty and attorneys’ fees.  The arbitrator also dismissed all counterclaims (which sought over $100 million in damages).
• An arbitration award in favor of independent trustees in a dispute involving contractual interpretation.
• An arbitration award in favor of an educational institution in a dispute over the interpretation of licensing agreements.  
• Summary judgment in favor of an educational institution in a wrongful death lawsuit brought by the family of a student who committed suicide. The lower court’s award of summary judgment was affirmed by the Supreme Judicial Court.
• Defense of a private equity firm against False Claims Act allegations relating to the operations of a portfolio company, which resulted in the Government’s decision to not pursue any claims against the firm.
• A successful motion to dismiss indemnification claims brought against a private equity firm by a former employee of a portfolio company. 
• Defense of large financial institutions and mortgage lenders against claims involving improper mortgage lending and servicing practices.  
• Representation of private equity firms, life sciences companies, and publicly-traded companies in responding to FINRA inquiries.
• Advice to a global private equity firm concerning litigation and regulatory risks and considerations in connection with due diligence into potential investments.